Most chronic
liver diseases are accompanied by oxidative stress, which may induce apoptosis in hepatocytes and liver injury. Oxidative stress induces
heme oxygenase-1 (HO-1) expression. This stress-responsive cytoprotective
protein is responsible for
heme degradation into
carbon monoxide (CO), free
iron, and
biliverdin. CO is an important intracellular messenger; however, the exact mechanisms responsible for its cytoprotective effect are not yet elucidated. Thus, we investigated whether HO-1 and CO protect primary hepatocytes against oxidative-stress-induced apoptosis. In vivo, bile duct
ligation was used as model of chronic
liver disease. In vitro, primary hepatocytes were exposed to the
superoxide anion donor
menadione in a normal and in a CO-- containing atmosphere. Apoptosis was determined by measuring
caspase-9, -6, -3 activity and
poly(ADP-ribose) polymerase cleavage, and
necrosis was determined by
Sytox green staining. The results showed that (1) HO-1 is induced in chronic cholestatic
liver disease, (2)
superoxide anions time- and dose-dependently induce HO-1 activity, (3) HO-1 overexpression inhibits
superoxide-
anions-induced apoptosis, and (4) CO blocks
superoxide-
anions-induced JNK phosphorylation and
caspase-9, -6, -3 activation and abolishes apoptosis but does not increase
necrosis. We conclude that HO-1 and CO protect primary hepatocytes against
superoxide-
anions-induced apoptosis partially via inhibition of JNK activity. CO could represent an important candidate for the treatment of
liver diseases.